Roche to Acquire AI Diagnostics Firm PathAI for Up to $1B
Roche agrees to acquire Boston AI diagnostics firm PathAI for up to $1B, targeting ML tools for tissue sample analysis — a major enterprise bet on AI-powered clinical pathology.
Roche agrees to acquire Boston AI diagnostics firm PathAI for up to $1B, targeting ML tools for tissue sample analysis — a major enterprise bet on AI-powered clinical pathology.